Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
The global AI boom is putting fresh pressure on electricity grids, and that matters for healthcare. British hospitals, clinics and drug researchers need reliable computing power to train medical algorithms and run data heavy tools, yet power costs and supply constraints keep
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- QQQ Invesco QQQ-9.8% 30d
Invesco QQQ: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story.
- XLU Utilities Select Sector SPDR+6.5% 12d
Utilities Select Sector SPDR: it holds power utilities. Linked by “electricity” (power and utilities) in this story.
- EWU iShares MSCI United Kingdom ETF+1.5% 7d
iShares MSCI United Kingdom ETF holds stocks listed in the UK, which this story is about (“british”).
- LLY Eli Lilly and+25.0% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | +5.96% | +2.17% | base | after close | after close | after close | after close |
| XBI | +4.00% | +3.40% | base | after close | after close | after close | after close |
| QQQ | +8.54% | +8.17% | base | after close | after close | after close | after close |
| XLUNo price data for this ticker | — | — | — | — | — | — | — |
| EWU | +6.36% | +2.98% | base | after close | after close | after close | after close |
| LLY | +6.37% | +2.56% | base | after close | after close | after close | after close |
| JNJ | +4.35% | +0.70% | base | after close | after close | after close | after close |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks Yahoo Finance
Source: Yahoo Finance
Price since this story was published: Select Sector Spdr Tr (XLV)
| Company | When | Move | Status |
|---|---|---|---|
| Ishares Tr (EWU) | three days earlier | +2.98% | final price |
| Ishares Tr (EWU) | five days earlier | +6.36% | final price |
| Johnson & Johnson (JNJ) | three days earlier | +0.70% | final price |
| Johnson & Johnson (JNJ) | five days earlier | +4.35% | final price |
| Eli Lilly (LLY) | three days earlier | +2.56% | final price |
| Eli Lilly (LLY) | five days earlier | +6.37% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | +8.17% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | +8.54% | final price |
| Spdr Series Trust (XBI) | three days earlier | +3.40% | final price |
| Spdr Series Trust (XBI) | five days earlier | +4.00% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +2.17% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | +5.96% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Michael Rulli sold Eli Lilly (LLY), worth $1,001 - $15,000 on 4 Nov 2026. That is 18 days before publication. Filed 18 Nov 2026. View the filing.
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 19 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 33 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 27 Oct 2026. That is 26 days before publication. Filed 19 Nov 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 46 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 53 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 79 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $15,001 - $50,000 on 2 Sep 2026. That is 81 days before publication. Filed 19 Nov 2026. View the filing.
- Rep. Michael Rulli bought Microsoft (MSFT), worth $1,001 - $15,000 on 4 Nov 2026. That is 18 days before publication. Filed 18 Nov 2026. View the filing.
- Rep. Rohit Khanna sold Microsoft (MSFT) (held by a dependent child), worth $1,001 - $15,000 on 28 Oct 2026. That is 25 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Microsoft (MSFT), worth $15,001 - $50,000 on 27 Oct 2026. That is 26 days before publication. Filed 19 Nov 2026. View the filing.
- Rep. Michael Rulli sold Alphabet (GOOGL), worth $1,001 - $15,000 on 4 Nov 2026. That is 18 days before publication. Filed 18 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies carried with this story
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 22 Nov 2026 story “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks.” Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
- XBI Spdr Series Trust
For “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks,” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
- QQQ Invesco Qqq Trust, Series 1
Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence in the 22 Nov 2026 story “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks.” Reason on file: Invesco QQQ: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story
- EWU Ishares Tr
Ishares Tr (EWU) is linked, with no stored direction, medium confidence in the 22 Nov 2026 story “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks.” Reason on file: iShares MSCI United Kingdom ETF holds stocks listed in the UK, which this story is about (“british”)
- LLY Eli Lilly
In “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- MSFT Microsoft
In “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks,” Microsoft (MSFT) is linked, with no stored direction, medium confidence. Reason on file: Microsoft (prepackaged software): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story
- JNJ Johnson & Johnson
In “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- GOOGL Alphabet
Alphabet (GOOGL) is linked, with no stored direction, medium confidence in the 22 Nov 2026 story “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks.” Reason on file: Alphabet (computer programming, data processing, etc.): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story
How “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks” reaches Select Sector Spdr Tr (XLV)
Select Sector Spdr Tr (XLV) is the company in “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks,” the 22 Nov 2026 this story story.
What ties Select Sector Spdr Tr (XLV) to the headline is this: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
Spdr Series Trust (XBI) is here too. Its reason reads: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
Price levels for Select Sector Spdr Tr (XLV)
QQQ traded between 680.34 and 752.84 across 19 sessions. The latest close on file is 685.32.
How solid “Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks” looks
46 out of 100
“Poolbeg Pharma Is Just One Of 3 British Healthcare AI Stocks” scores 46 out of 100. The score uses 1 source, and 8 linked companies.